Development and streamlined integration of 3D printing technologies to enable advanced medical treatment and its widespread application | 2 Mers Seas Zeeën

3DMed

Vous êtes ici

Development and streamlined integration of 3D printing technologies to enable advanced medical treatment and its widespread application

Priority Axis

Technological and Social Innovation

Specific objective

Technological Innovation

Netherlands

Technische Universiteit Delft [TUD]

Lead partner

address

Mekelweg 2
2628 CD Delft
Pays-Bas

Contact

Project budget

6 843 951

ERDF amount

4 106 370

ERDF rate

60%

Date de début

12/07/2018

Date de fin

30/09/2021

Common challenge

3D printing (3DP) technologies carry the promise of revolutionizing the quality and efficiency of healthcare. However, the required technologies, even when available, are currently too fragmented to be integrated into routine, affordable and streamlined solutions that can benefit a large number of patients. The challenge thereby is to deliver 3DP technologies enabling:

  • Patient-specific solutions: personalized medical devices that are designed using the images acquired for individual patients and best fit their treatment needs;
  • Complexity and miniaturization: complex shapes, articulations and miniaturized geometries of implantable medical devices and instruments have the potential to radically enhance treatment effectiveness and post-treatment recovery;
  • Streamlined care: the ability to integrate diagnosis, design and manufacturing of 3DP medical devices into a validated software platform is the key to delivering fast, affordable treatments with dramatic life-saving potential.

Partners

Netherlands

Stichting Materials innovation institute [M2i]

Belgium/Flanders

Universiteit Gent [UG]

France

Association pour la Recherche et le Développement des Méthodes et Processus Industriels [ARMINES]

Netherlands

EXO-L BV [EXO-L]

Netherlands

Dutch Ophthalmic Research Center (International) B.V. [DORC]

England

Meridian Technique Limited [MTL]

Netherlands

Amber Implants B.V. [AmI]

England

University of Oxford [UOx]

England

Oxford MESTAR Limited [OxMestar]

England

3D LifePrints [3DLP]

France

EURASANTÉ [Eurasanté]

France

Université de Lille [ULille]

Belgium/Flanders

Strategisch Initiatief Materialen [SIM]

Netherlands

Oceanz BV [Oceanz]

Belgium/Flanders

Avroxa bvba [AVR]

France

Régnier Orthopédie [Régnier]

Observers

Netherlands

Reinier de Graaf Groep [RdGG]

Belgium/Flanders

AZZENO/Cosmipolis Clinic [Azzeno]

Netherlands

University Medical Center Utrecht [UMCU]

England

Department of Plastic Surgery, Oxford University Hospitals NHS Foundation Trust [OUH]

Netherlands

Leiden University Medical Center [LUMC]

Belgium/Flanders

CADskills BVBA [CADskills]

Belgium/Flanders

Nelson Labs Europe NV [Nelson Labs]

Netherlands

DEAM BV [DEAM]

Netherlands

Dassault Systèmes [DS]

France

Medtronic [Medtronic]

France

LATTICE MEDICAL [LATTICE]

Belgium/Flanders

In4care vzw [In4care]

France

Cousin Biotech [Cousin Biotech]

Netherlands

Blue Sparrows MedTech Finance B.V. [Blue Sparrows]